KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.31 $5.74 Friday, 26th Apr 2024 VTGN stock ended at $4.75. This is 1.06% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.19% from a day low at $4.65 to a day high of $4.85.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
Aug 16, 2023 $6.09 $6.17 $5.60 $5.66 971 265
Aug 15, 2023 $6.57 $6.74 $5.91 $6.28 1 400 992
Aug 14, 2023 $6.20 $7.13 $6.12 $6.96 2 773 594
Aug 11, 2023 $6.99 $7.25 $5.91 $6.42 3 739 940
Aug 10, 2023 $7.69 $8.14 $7.08 $7.52 14 946 047
Aug 09, 2023 $8.40 $8.44 $6.80 $7.04 10 393 724
Aug 08, 2023 $11.30 $11.69 $7.30 $7.42 8 703 196
Aug 07, 2023 $21.60 $24.71 $10.70 $13.05 53 904 142
Aug 04, 2023 $1.68 $1.75 $1.63 $1.68 147 333
Aug 03, 2023 $1.75 $1.76 $1.65 $1.70 116 800
Aug 02, 2023 $1.78 $1.83 $1.72 $1.73 64 200
Aug 01, 2023 $1.83 $1.86 $1.77 $1.80 95 300
Jul 31, 2023 $1.82 $1.88 $1.76 $1.82 157 600
Jul 28, 2023 $1.69 $1.83 $1.69 $1.81 254 300
Jul 27, 2023 $1.73 $1.76 $1.65 $1.68 101 400
Jul 26, 2023 $1.68 $1.76 $1.67 $1.72 116 300
Jul 25, 2023 $1.84 $1.89 $1.71 $1.71 110 500
Jul 24, 2023 $1.85 $1.94 $1.80 $1.87 214 200
Jul 21, 2023 $1.87 $1.88 $1.81 $1.86 49 600
Jul 20, 2023 $1.86 $1.89 $1.81 $1.87 49 500
Jul 19, 2023 $1.81 $1.88 $1.79 $1.86 61 700
Jul 18, 2023 $1.81 $1.85 $1.76 $1.80 54 300
Jul 17, 2023 $1.77 $1.83 $1.69 $1.81 71 900
Jul 14, 2023 $1.82 $1.82 $1.72 $1.77 92 100
Jul 13, 2023 $1.75 $1.82 $1.73 $1.80 159 800
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT